New Published Study Demonstrates Safety and Feasibility of Filterlex Medical’s CAPTIS® Device in Providing Embolic Protection During TAVR
(Adnkronos) – Peer-Reviewed EuroIntervention Journal Publishes First-in-Human Study Finding Filterlex Medical’s CAPTIS® Embolic Protection Device Performed Well and is Safe During Transcatheter Aortic Valve Replacement (TAVR). CAESAREA, Israel, Nov. 15, 2023 /PRNewswire/
